First-in-Patient Dose Prediction for Adeno-Associated Virus-Mediated Hemophilia Gene Therapy Using Allometric Scaling
出版年份 2022 全文链接
标题
First-in-Patient Dose Prediction for Adeno-Associated Virus-Mediated Hemophilia Gene Therapy Using Allometric Scaling
作者
关键词
-
出版物
Molecular Pharmaceutics
Volume 20, Issue 1, Pages 758-766
出版商
American Chemical Society (ACS)
发表日期
2022-11-15
DOI
10.1021/acs.molpharmaceut.2c00555
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Perspective of DMPK on Recombinant Adeno-Associated Virus-Based Gene Therapy: Past Learning, Current Support, and Future Contribution
- (2022) Nancy Chen et al. AAPS Journal
- Safety of Adeno-associated virus-based vector-mediated gene therapy—impact of vector dose
- (2022) Shubham Maurya et al. CANCER GENE THERAPY
- Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapies
- (2021) Andreas L. Gimpel et al. Molecular Therapy-Methods & Clinical Development
- Rational Clinical Dose Selection of Adeno‐Associated Virus‐Mediated Gene Therapy Based on Allometric Principles
- (2021) Fei Tang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- T Cell-Mediated Immune Responses to AAV and AAV Vectors
- (2021) Hildegund C. J. Ertl Frontiers in Immunology
- Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia A
- (2021) K John Pasi et al. HAEMOPHILIA
- Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A
- (2021) Lindsey A. George et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical assessment of an optimized AAV-FVIII vector in mice and non-human primates for the treatment of hemophilia A
- (2021) Liron Elkouby et al. Molecular Therapy-Methods & Clinical Development
- Adeno-associated virus vector as a platform for gene therapy delivery
- (2019) Dan Wang et al. NATURE REVIEWS DRUG DISCOVERY
- The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene Therapy
- (2019) Brian R. Long et al. Molecular Therapy-Methods & Clinical Development
- Optimized Adeno-Associated Virus-Mediated Human Factor VIII Gene Therapy in Cynomolgus Macaques
- (2018) Jenny Greig et al. HUMAN GENE THERAPY
- Gene Therapy with BMN 270 Results in Therapeutic Levels of FVIII in Mice and Primates and Normalization of Bleeding in Hemophilic Mice
- (2018) Stuart Bunting et al. MOLECULAR THERAPY
- AAV5–Factor VIII Gene Transfer in Severe Hemophilia A
- (2017) Savita Rangarajan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Contemporary Animal Models For Human Gene Therapy Applications
- (2015) Chitra Gopinath et al. CURRENT GENE THERAPY
- Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
- (2014) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant
- (2013) J. McIntosh et al. BLOOD
- Selection and evaluation of clinically relevant AAV variants in a xenograft liver model
- (2013) Leszek Lisowski et al. NATURE
- Systemic Errors in Quantitative Polymerase Chain Reaction Titration of Self-Complementary Adeno-Associated Viral Vectors and Improved Alternative Methods
- (2012) Paolo Fagone et al. Human Gene Therapy Methods
- Clinical severity of haemophilia A: does the classification of the 1950s still stand?
- (2011) I. E. M. Den UIJL et al. HAEMOPHILIA
- Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical Trial
- (2011) James A. Allay et al. HUMAN GENE THERAPY
- Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins
- (2011) Amit C Nathwani et al. MOLECULAR THERAPY
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
- (2011) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhancing transduction of the liver by adeno-associated viral vectors
- (2008) A C Nathwani et al. GENE THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now